Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease

Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease

Abstract Background Peripheral arterial disease (PAD) of lower extremities comprises a clinical spectrum that extends from asymptomatic patients to critical limb ischemia (CLI) patients. 10% to 40% of the patients are at the risk of primary amputation. This study was planned in “no-option” patients...

Full description

Bibliographic Details
Main Authors: Pawan Kumar Gupta, P. Shivashankar, M. Rajkumar, Subhendu S. Mahapatra, Sanjay C. Desai, Anita Dhar, Vinay Krishna, N. S. Raviraja, Samatha Bhat, Pachaiyappan Viswanathan, Suresh Kannan, Jijy Abraham, Hema Boggarapu, M. S. Manjuprasad, K. Udaykumar
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stromal cells
Peripheral arterial disease
Ulcer healing
Ankle–brachial pressure index
Neovascularization
Online Access:https://doi.org/10.1186/s13287-023-03292-w

Internet

https://doi.org/10.1186/s13287-023-03292-w

Similar Items